Ken Griffin Inari Medical, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$37.11 - $50.69 $1.28 Million - $1.74 Million	34,400 Added 189.01%	52,600 $2.53 Million
Q1 2024 May 15, 2024	SELL	$40.65 - $65.76 $735,765 - $1.19 Million	-18,100 Reduced 49.86%	18,200 $873,000
Q4 2023 Feb 14, 2024	SELL	$48.3 - $68.06 $376,740 - $530,868	-7,800 Reduced 17.69%	36,300 $2.36 Million
Q3 2023 Nov 14, 2023	BUY	$54.2 - $71.67 $661,240 - $874,374	12,200 Added 38.24%	44,100 $2.88 Million
Q2 2023 Aug 14, 2023	BUY	$56.23 - $71.17 $567,923 - $718,817	10,100 Added 46.33%	31,900 $1.85 Million
Q1 2023 May 15, 2023	BUY	$53.43 - $68.12 $694,590 - $885,560	13,000 Added 147.73%	21,800 $1.35 Million
Q4 2022 Feb 14, 2023	SELL	$61.23 - $83.62 $2.31 Million - $3.15 Million	-37,700 Reduced 81.08%	8,800 $559,000
Q3 2022 Nov 14, 2022	BUY	$65.58 - $84.69 $72,138 - $93,159	1,100 Added 2.42%	46,500 $3.38 Million

261

55.1M

137K

25.9K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.34B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.